Neural regulation of intestinal smooth muscle growth in vitro.
The loss of intrinsic neurons is an early event in inflammation of the rat intestine that precedes the growth of intestinal smooth muscle cells (ISMC). To study this relationship, we cocultured ISMC and myenteric plexus neurons from the rat small intestine and examined the effect of scorpion venom, a selective neurotoxin, on ISMC growth. By 5 days after neuronal ablation, ISMC number increased to 141+/-13% (n = 6) and the uptake of [(3)H]thymidine in response to mitogenic stimulation was nearly doubled. Atropine caused a dose-dependent increase in [(3)H]thymidine uptake in cocultures, suggesting the involvement of neural stimulation of cholinergic receptors in regulation of ISMC growth. In contrast, coculture of ISMC with sympathetic neurons increased [(3)H]thymidine uptake by 45-80%, which was sensitive to propranolol (30 microM) and was lost when the neurons were separated from ISMC by a permeable filter. Western blotting showed that coculture with myenteric neurons increased alpha-smooth muscle-specific actin nearly threefold to a level close to ISMC in vivo. Therefore, factors derived from enteric neurons maintain the phenotype of ISMC through suppression of the growth response, whereas catecholamines released by neurons extrinsic to the intestine may stimulate their growth. Thus inflammation-induced damage to intestinal innervation may initiate or modulate ISMC hyperplasia.
Blennerhassett
M G
MG
Gastrointestinal Diseases Research Unit, Queens University, Hotel Dieu Hospital, Kingston, Ontario K7L 5G2, Canada.
Lourenssen
S
S
D000199:Actins / Q000032:analysis; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D015153:Blotting, Western; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D002799:Cholinergic Fibers / Q000187:drug effects / Q000502:physiology; D003106:Colon / Q000166:cytology / Q000254:growth & development / Q000294:innervation; D005730:Ganglionic Blockers / Q000494:pharmacology; D018738:Hexamethonium / Q000494:pharmacology; D066298:In Vitro Techniques; D007583:Jejunum / Q000166:cytology* / Q000254:growth & development / Q000294:innervation*; D008297:Male; D024510:Muscle Development; D018485:Muscle Fibers, Skeletal / Q000737:chemistry / Q000166:cytology; D009130:Muscle, Smooth / Q000166:cytology* / Q000254:growth & development / Q000294:innervation*; D009197:Myenteric Plexus / Q000166:cytology / Q000502:physiology*; D010276:Parasympatholytics / Q000494:pharmacology; D010641:Phenotype; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012604:Scorpion Venoms / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000166:cytology / Q000502:physiology
D000199:Actins; D000319:Adrenergic beta-Antagonists; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D012604:Scorpion Venoms; D018738:Hexamethonium; D001285:Atropine; D011433:Propranolol